Literature DB >> 19733430

Stress resistant human embryonic stem cells as a potential source for the identification of novel cancer stem cell markers.

Shaker A Mousa1, Thangirala Sudha, Evgeny Dyskin, Usawadee Dier, Christine Gallati, Christine Hanko, Sridar V Chittur, Abdelhadi Rebbaa.   

Abstract

Cancer stem cells are known for their inherent resistance to therapy. Here we investigated whether normal stem cells with acquired resistance to stress can be used to identify novel markers of cancer stem cells. For this, we generated a human embryonic stem cell line resistant to Trichostatin A and analyzed changes in its gene expression. The resistant cells over-expressed various genes associated with tumor aggressiveness, many of which are also expressed in the CD133+ glioma cancer stem cells. These findings suggest that stress-resistant stem cells generated in vitro may be useful for the discovery of novel markers of cancer stem cells. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19733430     DOI: 10.1016/j.canlet.2009.08.018

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  4 in total

Review 1.  An overview of the role of cancer stem cells in spine tumors with a special focus on chordoma.

Authors:  Mojdeh Safari; Alireza Khoshnevisan
Journal:  World J Stem Cells       Date:  2014-01-26       Impact factor: 5.326

2.  Elimination of head and neck cancer initiating cells through targeting glucose regulated protein78 signaling.

Authors:  Meng-Ju Wu; Chia-Ing Jan; Yeou-Guang Tsay; Yau-Hua Yu; Chih-Yang Huang; Shu-Chun Lin; Chung-Ji Liu; Yu-Syuan Chen; Jeng-Fan Lo; Cheng-Chia Yu
Journal:  Mol Cancer       Date:  2010-10-27       Impact factor: 27.401

Review 3.  Adaptive response of resistant cancer cells to chemotherapy.

Authors:  Yi-Jye Chern; Isabella T Tai
Journal:  Cancer Biol Med       Date:  2020-12-15       Impact factor: 4.248

4.  Histone acetylation-mediated regulation of the Hippo pathway.

Authors:  Dipanjan Basu; Miguel Reyes-Múgica; Abdelhadi Rebbaa
Journal:  PLoS One       Date:  2013-05-06       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.